-
Funding allows for expansion of labs, teams, and additional species candidates for de-extinction
-
Foundation awarded grants support cancer research efforts and domestic violence shelters across the U.S.
-
Following massive progress on the Woolly Mammoth and Tasmanian tiger, Colossal launches Avian Genomics Group to continue groundbreaking de-extinction pursuits
-
The de-extinction company doubles down on genomic sequencing of EEHV for the development of a vaccine that can eradicate one of the deadliest viruses affecting the endangered elephant
-
Hess Corporation to Make $9 Million, Three-Year Investment in Education in Houston’s Underserved Communities.
-
Global Genes launches RARE Health Equity Council to help build inclusive healthcare system and improve access for underserved rare disease patients.
-
Fellowship program honors Dr. Just, a pioneering biologist and one of the most prominent African American scientists of the twentieth century
-
Dr. Dina Mody Focuses on Latina Women With Limited Access to Health Care
-
Efforts focused on prevention and delivering life-saving tools and health services $170 million invested since corporate initiative began nearly two decades ago 700,000 health workers trained, 15 million bed nets and 5 million treatments delivered since 2000
-
10 programs selected to help support healthcare capacity building in resource-constrained countries More than $1 million in total provided to expand essential cancer care services
-
Komen-Funded research identifies previously unknown gene mutations associated with poor outcomes in estrogen-receptor-positive (ER+) breast cancer.